FY23 consensus $10.65. Raises FY23 revenue view to $98.8B-$99.8B from $97.9B-$98.9B, consensus $98.96B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JNJ:
- Johnson & Johnson Earnings Report: Is it a Beat?
- JNJ Up as Q2 Results Beat Estimates, Raises Outlook
- Notable companies reporting before tomorrow’s open
- Johnson & Johnson Stock (NYSE:JNJ): Medicare Negotiations and Q2 Earnings in Focus
- J&J ordered to pay $18.8M over baby powder claims, Bloomberg reports